::: hero

End-Stage Renal Disease is one of only three pathways to Medicare entitlement under age 65. Section 1881 of the Social Security Act, codified at 42 USC 1395rr and added by Section 2991 of the Social Security Amendments of 1972 (Public Law 92-603), makes Medicare benefits available to individuals of any age who require chronic dialysis or a kidney transplant. The 1972 statute was a landmark expansion: at the time, dialysis was a new and expensive technology with limited insurance coverage, and the social cost of denying coverage was the slow inevitability that uninsured patients would die from a treatable disease. Congress responded by creating a categorical Medicare entitlement that does not depend on age, work status, or income. Today, the ESRD Medicare program serves dialysis patients and kidney transplant recipients nationwide, funded primarily through the Medicare Hospital Insurance trust fund and Medicare Part B beneficiary premiums. For Georgia beneficiaries, the federal framework operates through multiple interconnected statutory and regulatory provisions: the entitlement rules under Section 1881(b), the 30-month coordination of benefits period under Section 1862(b)(1)(C), the ESRD Prospective Payment System under Section 1881(c) and the Medicare Improvements for Patients and Providers Act of 2008 (Public Law 110-275, Section 153), the post-transplant immunosuppressive drug coverage extension under Section 402 of Public Law 116-260, and the Medicare Advantage enrollment rights restored by Section 17006 of the 21st Century Cures Act (Public Law 114-255) effective January 1, 2021. This guide explains how Georgia beneficiaries qualify for ESRD Medicare, when entitlement begins, how the 30-month coordination period works for those with employer group health plan coverage, what dialysis and kidney transplant services Medicare covers, how the immunosuppressive drug benefit extension operates, what changed when ESRD beneficiaries gained Medicare Advantage enrollment rights, how ESRD Network 6 (Southeastern Kidney Council) operates in Georgia, and how dual-eligible Georgia ESRD beneficiaries coordinate Medicare with Georgia Medicaid. :::

::: callout

Key Takeaways for Georgia ESRD Beneficiaries

ESRD is a categorical Medicare entitlement under Section 1881 of the Social Security Act available regardless of age, income, or work status, provided the beneficiary or a qualifying family member has 40 quarters of Social Security coverage. The entitlement covers dialysis (in-center or home) and kidney transplant.

The 4-month waiting period applies to most dialysis beneficiaries (entitlement starts Month 4), but Month 1 entitlement is available for beneficiaries who complete self-care training and begin home dialysis within 3 months of starting dialysis. Pursuing home dialysis is the single most important financial strategy in early ESRD because it saves 3 months of out-of-pocket dialysis cost.

The 30-month coordination of benefits period under Section 1862(b)(1)(C) and 42 CFR 411.160-411.184 requires group health plans to pay primary for 30 months from Medicare ESRD eligibility regardless of the plan size or whether employment is current or former. After 30 months, Medicare becomes primary. Beneficiaries with comprehensive GHP coverage often delay Part B enrollment to avoid paying premiums while the GHP is primary.

The 21st Century Cures Act (Public Law 114-255) Section 17006 changed Medicare Advantage rules for ESRD beneficiaries effective January 1, 2021. Before 2021, ESRD beneficiaries were generally excluded from MA except limited Special Needs Plans. After 2021, ESRD beneficiaries can enroll in any MA plan on the same basis as other beneficiaries. MA plans cannot deny enrollment or use medical underwriting based on ESRD status.

The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020 (Section 402 of Public Law 116-260) extended Medicare Part B coverage of immunosuppressive drugs for kidney transplant recipients past the 36-month entitlement end for lifetime coverage. The benefit is immunosuppressive-only (called Part B-ID) and does not include other Part A or B services. Recipients must enroll through SSA and pay a separate Part B-ID premium.

For Georgia, ESRD Network 6 (Southeastern Kidney Council) is the federally contracted ESRD Network serving Georgia, North Carolina, and South Carolina. Network 6 handles ESRD-specific grievances about dialysis facilities and provides beneficiary services distinct from plan grievances and KEPRO QIO reviews. :::

Section 1881 of the Social Security Act: The Statutory Foundation

Section 1881 of the Social Security Act, codified at 42 USC 1395rr, is the statutory basis for the entire Medicare ESRD program. The provision was added by Section 2991 of the Social Security Amendments of 1972 (Public Law 92-603), signed October 30, 1972, with the substantive ESRD entitlement effective July 1, 1973. The 1972 amendments responded to the political and clinical reality that maintenance dialysis had become a survival-essential treatment for chronic kidney failure, but that fewer than a third of patients with ESRD had insurance coverage adequate to pay for dialysis. Congress created a categorical Medicare entitlement extending benefits to individuals of any age who require dialysis or kidney transplant, provided they meet insured status requirements.

Section 1881(b) sets out the eligibility framework. Subsection (b)(1) requires that the individual:

  • Have chronic kidney failure requiring regular course of dialysis or kidney transplant to maintain life
  • Be fully insured under Social Security (40 quarters of coverage), be currently entitled to monthly Social Security or Railroad Retirement benefits, OR be the spouse or dependent child of an individual who meets one of these criteria

The Section 1881(b)(1) framework means that ESRD Medicare is not means-tested. An ESRD beneficiary may be wealthy or poor, employed or unemployed, age 25 or age 64. As long as the individual or a qualifying family member has 40 work quarters of Social Security coverage and the individual has ESRD, the individual is entitled.

Section 1881(b)(4) establishes the 30-month coordination of benefits period during which group health plan coverage pays primary and Medicare pays secondary. This protection has profound financial consequences for Georgia beneficiaries with employer-sponsored insurance, which we explain in detail below.

Section 1881(c) establishes the payment framework. The Medicare Improvements for Patients and Providers Act of 2008 (MIPPA, Public Law 110-275) Section 153 implemented the ESRD Prospective Payment System (ESRD PPS) effective January 1, 2011, replacing the previous composite rate structure with a bundled per-treatment payment that includes dialysis treatments, ESRD-related drugs (including erythropoiesis-stimulating agents like Epogen and Aranesp), laboratory tests, and supplies. The Affordable Care Act of 2010 (Public Law 111-148) Section 3401 expanded the bundled payment further by incorporating previously separately billable items.

Section 1881(d) authorizes the ESRD Network organizations. CMS contracts with 18 ESRD Networks nationwide to provide beneficiary education, grievance investigation, quality monitoring, and data collection. ESRD Network 6 (Southeastern Kidney Council) serves Georgia along with North Carolina and South Carolina.

Effective Date Rules for ESRD Medicare Entitlement (42 CFR 406.13)

The regulatory framework at 42 CFR 406.13 establishes when ESRD Medicare entitlement begins. The rules vary based on treatment modality and whether self-care training occurs.

Standard dialysis (in-center hemodialysis without self-care training). Entitlement begins the first day of the third month following the month dialysis begins. This is the 4-month waiting period. For a beneficiary who begins dialysis in January 2026, Medicare ESRD entitlement starts April 1, 2026.

Home dialysis with early self-care training (Month 1 entitlement). If the beneficiary completes self-care dialysis training and home dialysis begins within 3 months of starting dialysis, entitlement begins the first day of the month dialysis began. This is the Month 1 entitlement rule. For a beneficiary who begins dialysis in January 2026 and starts home dialysis after training in February 2026, Medicare ESRD entitlement starts January 1, 2026. This saves 3 months of out-of-pocket dialysis costs and is the single most important financial strategy in early-stage ESRD planning.

Kidney transplant. Entitlement begins the month the beneficiary is admitted as an inpatient to a Medicare-approved transplant hospital, provided the transplant occurs that month or in the following 2 months. If transplant occurs more than 2 months after admission, entitlement begins 2 months before the month of transplant.

Entitlement termination. ESRD Medicare entitlement ends 12 months after the last month of dialysis if dialysis is no longer required, OR 36 months after a successful kidney transplant. Under Section 402 of Public Law 116-260, the 36-month transplant entitlement now continues for immunosuppressive drug coverage only (Part B-ID) for the lifetime of the recipient, but other Part A and Part B services end at 36 months for under-65 recipients without another Medicare entitlement pathway.

The 30-Month Coordination of Benefits Period

The 30-month coordination of benefits period is the most consequential financial provision in the ESRD Medicare framework for beneficiaries with employer-sponsored insurance. Section 1862(b)(1)(C) of the Social Security Act and the implementing regulations at 42 CFR 411.160 through 42 CFR 411.184 establish that when a Medicare ESRD beneficiary also has group health plan coverage, the GHP pays primary for 30 months from the first month of Medicare ESRD eligibility, and Medicare pays secondary during that period. After the 30-month coordination period ends, Medicare becomes primary and the GHP becomes secondary.

The rule has several distinctive features that beneficiaries often misunderstand.

Plan size is irrelevant. Unlike the general Medicare Secondary Payer rule for working-aged individuals (which applies only to GHPs with 20+ employees) and the disability MSP rule (which applies only to GHPs with 100+ employees), the ESRD MSP rule applies to all GHPs regardless of size. A self-employed individual covered under a small business association GHP and a corporate executive covered under a Fortune 500 GHP are subject to the same 30-month rule.

Employment status is irrelevant. The ESRD MSP rule applies whether the GHP coverage is based on current employment, former employment (retiree coverage), COBRA continuation, or a spouse's coverage. The 30-month coordination applies as long as GHP coverage exists.

The 30-month clock starts at Medicare eligibility, not enrollment. A beneficiary who is eligible for Medicare ESRD entitlement starting April 1, 2026, but who delays Part B enrollment, still has the 30-month clock running from April 1, 2026. The clock does not pause for delayed enrollment.

The 30-month clock runs only once. If the beneficiary loses GHP coverage during the 30-month period, the clock continues to run. If GHP coverage is regained later, the remaining months of the original 30-month period apply.

The strategic implication for beneficiaries with comprehensive GHP coverage is significant. The beneficiary can delay enrolling in Medicare Part B to avoid paying the standard Part B premium while the GHP is primary. The beneficiary should still enroll in Part A (no premium for most beneficiaries) for hospital coverage backup. Near the end of the 30-month period, the beneficiary should enroll in Part B to avoid Medicare becoming primary while uncovered by Part B, which would expose the beneficiary to large out-of-pocket dialysis costs.

For beneficiaries with limited or expensive GHP coverage, the strategic calculation is different. Enrolling in Medicare Part B early provides secondary coverage that fills GHP gaps, reduces out-of-pocket cost, and provides comprehensive backup if GHP coverage is terminated.

The 30-month period also affects employer behavior. Some employers, recognizing the high cost of ESRD treatment, have terminated or restricted GHP coverage for employees with ESRD. The Centers for Medicare and Medicaid Services has taken enforcement action under 42 CFR 411.108 against employers and plans that take into account Medicare entitlement based on ESRD when offering or terminating GHP coverage. The MSP nondiscrimination provisions prohibit GHPs from terminating coverage, reducing benefits, or charging differential premiums based on ESRD status.

The ESRD Prospective Payment System

The ESRD Prospective Payment System, established by the Medicare Improvements for Patients and Providers Act of 2008 (Public Law 110-275) Section 153 and effective January 1, 2011, transformed how Medicare pays for dialysis. Before ESRD PPS, dialysis facilities billed Medicare separately for dialysis treatments, ESAs, iron therapy, laboratory tests, and various other services. The fragmented billing created incentives for over-prescription of expensive ESAs (which became a major Medicare cost concern in the late 2000s) and complex coding disputes.

ESRD PPS bundles payment for dialysis-related items into a single per-treatment payment. The bundle includes:

  • Dialysis treatment (typically 3 sessions per week for in-center hemodialysis)
  • ESAs (erythropoiesis-stimulating agents like Epogen, Aranesp, Mircera)
  • Iron therapy
  • Vitamin D analogs and other ESRD-related drugs
  • ESRD-related laboratory tests
  • Supplies and equipment
  • Home dialysis training

The base rate is updated annually through CMS rulemaking. The base rate is adjusted for case-mix factors (patient age, body surface area, low body weight, comorbidities) and facility-level factors (wages, low-volume payment adjustment, rural payment adjustment).

ESRD PPS includes a Quality Incentive Program (QIP) that links payment to facility performance on dialysis quality measures. Facilities that perform poorly on QIP measures receive payment reductions of up to 2 percent.

For beneficiaries, the practical effect of ESRD PPS is that dialysis facility services are paid as a bundle. Out-of-pocket cost for dialysis under Original Medicare typically involves Part B 20 percent coinsurance after the Part B deductible, subject to Medigap or Medicaid coverage of the coinsurance for those with secondary coverage.

For ESRD beneficiaries enrolled in Medicare Advantage post-Cures Act, the ESRD PPS bundled payment still applies at the facility level. MA plans contract with dialysis facilities and pay according to negotiated rates, but the underlying payment structure follows ESRD PPS principles. Beneficiary out-of-pocket cost for dialysis under MA depends on the plan's cost-sharing structure, which often includes a copayment per dialysis session capped by the MA plan's out-of-pocket maximum under 42 CFR 422.100(f)(4).

The 21st Century Cures Act and Medicare Advantage Enrollment for ESRD Beneficiaries

Section 17006 of the 21st Century Cures Act (Public Law 114-255), enacted December 13, 2016 and effective January 1, 2021, was a transformative change for ESRD beneficiaries. Before 2021, ESRD beneficiaries were generally prohibited from enrolling in Medicare Advantage plans under Section 1851(a)(3) of the Social Security Act. The exceptions were limited: ESRD beneficiaries already enrolled in an MA plan when they developed ESRD could remain in the plan, and ESRD beneficiaries could enroll in ESRD Chronic Condition Special Needs Plans (C-SNPs) designed for the ESRD population. The exclusion meant that most ESRD beneficiaries remained in Original Medicare regardless of preference.

Section 17006 of the Cures Act lifted this restriction effective January 1, 2021. ESRD beneficiaries can now enroll in any Medicare Advantage plan on the same basis as other Medicare beneficiaries. The implementing regulation at 42 CFR 422.50 was amended to remove the ESRD exclusion. CMS guidance confirms that:

  • MA plans cannot deny enrollment based on ESRD status
  • MA plans cannot use medical underwriting for ESRD beneficiaries
  • ESRD beneficiaries can enroll during the Annual Election Period (October 15 through December 7), during their Initial Coverage Election Period, during the Medicare Advantage Open Enrollment Period (January 1 through March 31), or during any applicable Special Enrollment Period
  • ESRD beneficiaries enrolled in MA receive ESRD-related care through the MA plan's network of dialysis facilities and transplant programs
  • ESRD beneficiaries can switch between MA plans or to Original Medicare under standard election period rules

The market impact has been significant. ESRD beneficiaries make up a small but high-cost population, and MA plans now compete for ESRD enrollees. Plans often include features specifically valuable to ESRD beneficiaries: non-emergency medical transportation (NEMT) to dialysis appointments, healthy food cards for renal-friendly diets, care coordination focused on cardiovascular comorbidities common in ESRD, and integrated transplant referral programs.

Two important considerations remain. First, network adequacy is critical. ESRD beneficiaries need to verify that their preferred dialysis facility and transplant program participate in the MA plan's network. Out-of-network dialysis can cost the beneficiary substantially more or in some plan designs not be covered at all. Second, dialysis is a high-utilization service. ESRD beneficiaries can expect to receive dialysis three times per week (in-center hemodialysis) or daily (home dialysis), and the cumulative cost-sharing under MA can be substantial unless the plan structures cost-sharing favorably or the beneficiary qualifies for QMB or Medicaid secondary coverage.

Kidney Transplant Coverage and the Immunosuppressive Drug Extension

Medicare covers kidney transplantation comprehensively. Medicare Part A pays for the inpatient transplant surgery, the donor evaluation and surgery (whether living or deceased donor), the hospital stay, and post-transplant inpatient care. Medicare Part B pays for pre-transplant evaluation, outpatient physician services, and immunosuppressive drugs.

The standard post-transplant Medicare entitlement under Section 1881 runs for 36 months after a successful kidney transplant. During this 36-month period, all Part A and Part B services continue. After 36 months, Medicare entitlement based on ESRD ends, unless the beneficiary qualifies under another pathway (age 65+ under Section 226(a), or disability under Section 226(b)).

The 36-month rule created a major problem before 2023. Immunosuppressive drugs are expensive and lifelong required after kidney transplant. Patients who lost Medicare coverage at month 37 often could not afford immunosuppressives. Medication non-adherence led to organ rejection, costly transplant failure, return to dialysis (and back onto Medicare), and in some cases death. The clinical and financial logic of cutting off immunosuppressive coverage while incurring the enormous cost of re-dialysis was indefensible.

Congress addressed the problem in the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020, enacted as Section 402 of the Consolidated Appropriations Act of 2021 (Public Law 116-260). Kidney transplant recipients whose Medicare entitlement would otherwise end 36 months post-transplant can now elect to continue Part B coverage for immunosuppressive drugs only. This is called "Medicare Part B-ID" (Immunosuppressive Drug only).

Key features of the Part B-ID benefit:

  • Coverage for immunosuppressive drugs is lifetime
  • Coverage includes immunosuppressive drug-related laboratory monitoring
  • Coverage does NOT include other Part A or Part B services
  • A separate Part B-ID premium applies, set annually by CMS
  • Recipients must enroll through SSA before the 36-month entitlement end
  • Recipients must rely on other coverage (Marketplace, Medicaid, COBRA, employer GHP) for non-immunosuppressive medical needs

For Georgia transplant recipients, the Part B-ID extension is a significant policy improvement. Recipients should plan for the transition: enroll in Part B-ID before month 37, ensure other comprehensive coverage is in place for non-immunosuppressive needs, and verify that immunosuppressive prescriptions are filled at Medicare-approved pharmacies.

Recipients who qualify for Medicare under another pathway (age 65+ or disability) do not need Part B-ID because their full Medicare continues. For example, a beneficiary who is age 70 and receives a kidney transplant retains full Medicare coverage based on age. The 36-month rule applies only to beneficiaries whose sole Medicare entitlement basis is ESRD.

ESRD Network 6: The Southeastern Kidney Council

ESRD Network 6, known as the Southeastern Kidney Council, is the federally contracted ESRD Network serving Georgia, North Carolina, and South Carolina under Section 1881(d) of the Social Security Act. Network 6 has administrative offices in Raleigh, North Carolina.

The ESRD Networks were established by Congress to provide a regional infrastructure for beneficiary services, quality monitoring, and data collection at the dialysis facility level. The 18 ESRD Networks nationwide operate under CMS contracts and report to CMS on facility quality metrics, beneficiary grievance trends, and clinical outcomes data.

For Georgia beneficiaries, Network 6 functions include:

Beneficiary services and grievances. Network 6 receives complaints from ESRD beneficiaries about dialysis facilities, including quality of care, provider conduct, facility cleanliness, scheduling, and access issues. Network 6 investigates complaints, may visit facilities, and may refer matters to CMS for enforcement action under 42 CFR Part 488 Subpart U (ESRD facility certification) or 42 CFR Part 494 (ESRD Conditions for Coverage).

Quality monitoring. Network 6 monitors dialysis facility performance on quality measures including hospitalization rates, mortality rates, vascular access infections, dialysis adequacy (Kt/V), and patient experience. The Network's monitoring contributes to the CMS ESRD Quality Incentive Program (QIP).

Transplant coordination. Network 6 supports transplant referral processes, encouraging timely transplant evaluation for dialysis patients. Georgia transplant programs at Emory, Piedmont Atlanta, Wellstar Atlanta Medical Center, Augusta University, and Children's Healthcare of Atlanta coordinate with Network 6 for referral and waitlist management.

Patient and family advisory councils. Network 6 convenes advisory groups including ESRD beneficiaries and family members to provide input on Network priorities and patient experience.

Data collection. Network 6 collects and reports data to CMS that feeds the ESRD Surveillance System and various public reports including the United States Renal Data System (USRDS) Annual Data Report.

Beneficiaries can file grievances with Network 6 in parallel with plan grievances (under 42 CFR 422.564 for MA enrollees) and KEPRO QIO complaints (under Section 1154 of the Social Security Act). Each channel has distinct jurisdiction and remedies; Network 6 is the ESRD-specific channel.

Dual-Eligible ESRD Beneficiaries in Georgia

Many Georgia ESRD beneficiaries also qualify for Medicaid through one of several pathways. ESRD itself does not automatically qualify a beneficiary for Medicaid, but the financial burden of ESRD (lost income from inability to work, high cost-sharing) often pushes beneficiaries below Medicaid income and resource limits.

For Georgia dual-eligible ESRD beneficiaries, coordination of Medicare and Medicaid is critical. The relevant frameworks include:

Qualified Medicare Beneficiary (QMB) program. Beneficiaries with income at or below 100% of the Federal Poverty Level and resources within QMB limits qualify for Medicaid payment of Medicare premiums and cost-sharing under 42 USC 1396a(a)(10)(E)(i). For ESRD beneficiaries, QMB protection means Medicaid pays the Part B premium, the Part B 20% coinsurance on dialysis services, and other Medicare cost-sharing. The 42 CFR 422.504(g)(1) improper billing protections prohibit providers and MA plans from billing QMB-eligible dual-eligibles for Medicare cost-sharing.

Specified Low-Income Medicare Beneficiary (SLMB). Beneficiaries with income between 100% and 120% FPL qualify for Medicaid payment of Part B premium only.

Full Medicaid eligibility. Beneficiaries who qualify for full Medicaid (through SSI, age 65+ with income at or below SSI levels, or other pathways) receive comprehensive Medicaid coverage including services Medicare does not cover (extended skilled nursing facility stays, home and community based services through waivers like the Community Care Services Program).

D-SNP enrollment. Medicare Advantage Dual-Eligible Special Needs Plans (D-SNPs) coordinate Medicare and Medicaid benefits for dual-eligible beneficiaries. Many D-SNPs in Georgia include ESRD-specific case management and care coordination services.

The Georgia Department of Community Health (DCH) is the state Medicaid agency. Member services handles Medicaid eligibility questions, plan enrollment, and dual-eligible coordination concerns. DCH coordinates with CMS Region IV Atlanta on dual-eligible policy and operational issues.

Worked Examples: Six Georgia ESRD Scenarios

Example 1: Margaret, Age 58, Atlanta, Employed with Group Health Plan, 30-Month Coordination Period

Margaret is 58 and works as a senior accountant at a large Atlanta employer with comprehensive group health plan coverage. In January 2026, after months of progressive fatigue and elevated creatinine, Margaret is diagnosed with ESRD and begins in-center hemodialysis three times per week. Because Margaret does not pursue self-care training, the standard 4-month waiting period applies. Her Medicare ESRD entitlement begins April 1, 2026.

Margaret's GHP provides comprehensive coverage with a low deductible and reasonable out-of-pocket maximum. Margaret coordinates with her employer's benefits department and with GeorgiaCares to plan her enrollment strategy. The 30-month coordination period runs from April 2026 through September 2028. During this period, the GHP pays primary for dialysis and other medical services. Medicare can pay secondary if Margaret enrolls in Part A and Part B.

Margaret enrolls in Medicare Part A (no premium) in April 2026 for inpatient coverage backup. She delays Part B enrollment to avoid paying the standard Part B premium while her GHP is primary. Near the end of the 30-month period, in July 2028, Margaret enrolls in Part B to be in effect by October 2028 when the GHP becomes secondary.

Margaret's strategic delay saves significant Part B premiums over 30 months. She also coordinates with her dialysis facility (DaVita Atlanta) to ensure her GHP is correctly identified as primary payer, avoiding billing errors that often occur with ESRD beneficiaries.

Example 2: Robert, Age 62, Savannah, Retired Without GHP, Standard 4-Month Waiting Period

Robert is 62, retired from his prior employment without retiree health coverage, and lives in Savannah. In February 2026, he is diagnosed with ESRD and begins in-center hemodialysis. He has no GHP coverage, so the 30-month coordination period does not apply. His Medicare ESRD entitlement begins May 1, 2026 (Month 4).

Robert enrolls in both Part A and Part B immediately. He has the option to enroll in Original Medicare with a Medigap policy (Plan G) and standalone Part D, or in Medicare Advantage. Robert chooses Original Medicare with Medigap Plan G because he wants predictable cost-sharing and broad provider network. Medigap covers the Part B 20% coinsurance on dialysis, leaving Robert with no out-of-pocket cost for dialysis services beyond his premiums.

Robert pays the standard Part B premium, the Medigap Plan G premium (approximately $300 monthly for a 62-year-old male in Savannah), and a standalone Part D plan premium (approximately $40 monthly). His combined Medicare-related premiums are manageable, and his out-of-pocket cost for medical services is minimal.

Example 3: Linda, Age 55, Macon, Home Peritoneal Dialysis with Month 1 Entitlement

Linda is 55 and chooses home peritoneal dialysis (continuous ambulatory peritoneal dialysis, CAPD) at the recommendation of her nephrologist. Linda begins self-care training at a Medicare-approved CAPD training program in January 2026. Her home CAPD begins in February 2026, within 3 months of her first dialysis treatment.

Because Linda completed self-care training and began home dialysis within 3 months of starting dialysis, the Month 1 entitlement rule under 42 CFR 406.13 applies. Her Medicare ESRD entitlement begins January 1, 2026, the first day of the month she began dialysis. This saves 3 months of out-of-pocket dialysis cost (which can be substantial at full provider charges, though secondary coverage if any would mitigate this).

Linda enrolls in Part A and Part B immediately. She has limited income and qualifies for QMB through Georgia Medicaid. QMB covers her Part B premium, deductible, and coinsurance, including the 20% coinsurance on CAPD-related services. Linda's effective out-of-pocket cost for dialysis is $0.

Example 4: Charles, Age 65, Augusta, Kidney Transplant with Lifetime Medicare

Charles is 65 and already entitled to Medicare based on age (Section 226(a)). He has been on dialysis for two years and his transplant evaluation has been completed. In March 2026, Charles receives a deceased-donor kidney transplant at Emory University Hospital.

Medicare Part A covers the inpatient transplant surgery and the seven-day hospital stay. Medicare Part B covers pre-transplant evaluation, outpatient physician services, and post-transplant immunosuppressive drugs. Because Charles is already Medicare-entitled based on age 65, his Medicare coverage continues lifetime regardless of the 36-month rule for ESRD-only beneficiaries.

Charles's immunosuppressive drugs (tacrolimus, mycophenolate, prednisone) are covered under standard Part B for life. His Medigap Plan G covers Part B coinsurance, so his out-of-pocket cost for immunosuppressives is minimal beyond his premiums.

Example 5: Patricia, Age 60, Columbus, MA Enrollment Post-Cures Act

Patricia is 60 and has had ESRD since 2023 on Medicare entitlement under Section 1881. Before 2021, she could not enroll in Medicare Advantage. Section 17006 of the 21st Century Cures Act effective January 1, 2021 changed this. During the 2025 Annual Election Period (October 15 to December 7, 2025), Patricia evaluates her options for the 2026 plan year.

Patricia uses GeorgiaCares to compare Original Medicare with Medigap (cost approximately $400-$500 monthly all-in) against MA plans. She identifies a Humana MA-PD plan with $0 premium that includes her dialysis facility (Fresenius Columbus) in network, transportation to dialysis appointments (3 round trips per week), a $100 monthly healthy food card, and a $4,000 out-of-pocket maximum on Part C services.

Patricia enrolls in the Humana MA-PD plan effective January 1, 2026. The plan accepts her enrollment without medical underwriting under Section 17006. Her dialysis facility bills the plan, which pays under negotiated rates. Patricia's cost-sharing for dialysis is a $25 copayment per session, capped by the plan's out-of-pocket maximum.

The post-Cures Act ability to enroll in MA opens significant savings for Patricia compared to Original Medicare plus Medigap, and gives her access to ancillary benefits valuable to her ESRD-related needs.

Example 6: Henry, Age 52, Athens, Dual-Eligible ESRD with D-SNP

Henry is 52 and has been disabled since age 47 due to a workplace injury. He receives SSDI and Medicare based on disability (Section 226(b)) and Medicaid based on income (Section 1902(a)(10)(A)(i)(II) categorical eligibility based on SSI). In 2024, Henry develops ESRD as a complication of long-standing diabetes. His Medicare entitlement is already in place based on disability; ESRD does not add a new Medicare entitlement, but it does subject him to ESRD-specific payment and coordination rules.

Henry enrolls in a Georgia D-SNP (Dual-Eligible Special Needs Plan) under 42 CFR 422.4. The D-SNP coordinates his Medicare and Medicaid benefits, includes ESRD-specific case management, and operates an integrated care team that coordinates between his nephrologist, primary care physician, dialysis facility (DaVita Athens), and endocrinologist.

Under the QMB protections at 42 CFR 422.504(g)(1), the D-SNP cannot bill Henry for any Medicare cost-sharing. Medicaid pays his Medicare cost-sharing, his Part B premium, and any additional services Medicare does not cover. Henry's effective out-of-pocket cost for dialysis, physician visits, hospital admissions, and prescription drugs is $0.

The dual-eligible coordination is particularly valuable for Henry because ESRD has high coordination requirements: dialysis three times per week, frequent medication adjustments, comorbid diabetes management, vascular access maintenance, and transplant evaluation. The D-SNP's integrated care team manages these elements as a coordinated whole.

Fourteen Common Mistakes Georgia ESRD Beneficiaries Should Avoid

Not applying for ESRD Medicare immediately. Application happens through the dialysis facility's Form CMS-2728 submission. Delayed application means delayed entitlement and out-of-pocket exposure.

Not pursuing self-care training to qualify for Month 1 entitlement. Beneficiaries who complete self-care training and begin home dialysis within 3 months of starting dialysis save 3 months of waiting. This is the single highest-value financial decision in early ESRD.

Misunderstanding the 30-month coordination period as exclusion from Medicare. The 30-month period is primary-secondary coordination, not exclusion. Medicare can pay secondary during the 30 months.

Enrolling in Part B unnecessarily when GHP is primary. For beneficiaries with comprehensive GHP coverage, delaying Part B enrollment saves premiums while the GHP is primary. Near the end of the 30-month period, enroll in Part B.

Missing the Part B Late Enrollment Penalty deadlines. Failing to enroll in Part B before the 30-month period ends results in coverage gaps. Plan enrollment around the coordination period.

Assuming ESRD beneficiaries cannot enroll in MA. This was true before 2021. Section 17006 of the 21st Century Cures Act lifted the exclusion effective January 1, 2021. ESRD beneficiaries can enroll in MA on the same basis as others.

Not understanding the Part B-ID immunosuppressive extension. Section 402 of Public Law 116-260 extended Part B immunosuppressive coverage for kidney transplant recipients past 36 months for lifetime coverage. Apply through SSA before month 37.

Choosing an MA plan without verifying dialysis facility network inclusion. ESRD beneficiaries need network adequacy specifically for their dialysis facility. Out-of-network dialysis is often not covered or has high cost-sharing.

Not enrolling in Part D for non-ESRD medications. ESRD PPS covers ESRD-related drugs bundled with dialysis. Non-ESRD medications (cardiovascular, diabetes, other comorbidities) require Part D.

Failing to coordinate with Medicaid for dual-eligible cost-sharing. QMB protections under 42 CFR 422.504(g)(1) eliminate out-of-pocket cost for dual-eligible beneficiaries. Apply for Medicaid if income/resources qualify.

Missing transplant evaluation timelines. Transplant evaluation should begin early in dialysis. Delayed referral extends time on the transplant waitlist and increases morbidity and mortality.

Not understanding the 36-month post-transplant entitlement end. For under-65 transplant recipients without disability entitlement, full Medicare ends 36 months post-transplant (immunosuppressive-only Part B-ID continues). Plan other coverage in advance.

Confusing ESRD entitlement with disability entitlement. ESRD entitlement under Section 1881 has different rules than disability entitlement under Section 226(b). Beneficiaries entitled under both pathways use the more favorable rules.

Not using ESRD Network 6 for facility-specific grievances. ESRD Network 6 (919-855-0882) handles complaints about dialysis facilities that may not be addressed through plan grievances or KEPRO QIO review.

::: accordion

Frequently Asked Questions

Section 1881 of the Social Security Act, codified at 42 USC 1395rr, added by Section 2991 of the Social Security Amendments of 1972 (Public Law 92-603). Effective July 1, 1973. The statute makes Medicare available to individuals of any age who require dialysis or kidney transplant, provided they meet insured status requirements.

Who is eligible for ESRD Medicare?

Individuals of any age with chronic kidney failure requiring regular dialysis or kidney transplant, AND who are fully insured under Social Security (40 quarters of coverage), entitled to monthly Social Security or Railroad Retirement benefits, OR the spouse or dependent child of an individual meeting those criteria.

When does ESRD Medicare entitlement begin?

For in-center dialysis without self-care training: the first day of the third month following the month dialysis begins (Month 4). For home dialysis with self-care training within 3 months: the first day of the month dialysis began (Month 1). For kidney transplant: the month admitted to a Medicare-approved transplant hospital if transplant occurs that month or in the following 2 months, otherwise 2 months before transplant.

What is the 30-month coordination of benefits period?

Under Section 1862(b)(1)(C) and 42 CFR 411.160-411.184, when a Medicare ESRD beneficiary also has group health plan coverage, the GHP pays primary for 30 months from the first month of Medicare ESRD eligibility. After 30 months, Medicare becomes primary. The rule applies regardless of plan size or employment status.

Can my employer terminate my GHP coverage because I have ESRD?

No. The Medicare Secondary Payer nondiscrimination provisions at 42 CFR 411.108 prohibit GHPs from terminating coverage, reducing benefits, or charging differential premiums based on ESRD status. CMS can take enforcement action against violators.

What is the ESRD Prospective Payment System?

ESRD PPS is the Medicare payment system for dialysis facilities, established by MIPPA 2008 Section 153 (Public Law 110-275) and effective January 1, 2011. It bundles dialysis treatments, ESRD-related drugs (including ESAs), laboratory tests, and supplies into a single per-treatment payment. Codified at 42 CFR 413.170-413.232.

What is included in the ESRD PPS bundle?

Dialysis treatment, erythropoiesis-stimulating agents, iron therapy, vitamin D analogs, ESRD-related laboratory tests, supplies, equipment, and home dialysis training. Non-ESRD-related drugs are not bundled and require separate coverage (typically Part D for prescription drugs).

Can I enroll in Medicare Advantage if I have ESRD?

Yes, effective January 1, 2021 under Section 17006 of the 21st Century Cures Act (Public Law 114-255). MA plans cannot deny enrollment or use medical underwriting based on ESRD. You can enroll during AEP (Oct 15 - Dec 7), MA OEP (Jan 1 - Mar 31), or applicable SEPs.

What should I look for in an MA plan as an ESRD beneficiary?

Network adequacy for your preferred dialysis facility and transplant program, cost-sharing structure for dialysis (per-session copayment vs. coinsurance), out-of-pocket maximum, ancillary benefits like transportation to dialysis or healthy food cards, and integrated care coordination for ESRD comorbidities.

Does Medicare cover kidney transplant?

Yes. Part A covers the inpatient surgery, donor evaluation and surgery, hospital stay, and post-transplant inpatient care. Part B covers pre-transplant evaluation, outpatient physician services, and immunosuppressive drugs.

When does Medicare end after a successful kidney transplant?

For beneficiaries whose Medicare entitlement is based solely on ESRD: 36 months after the transplant. For beneficiaries who also qualify under age (65+) or disability (24-month SSDI waiting period), Medicare continues lifetime.

What is Part B-ID and how does it extend immunosuppressive coverage?

Section 402 of Public Law 116-260 (Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020) created Part B-ID effective January 1, 2023. It extends Part B coverage of immunosuppressive drugs for kidney transplant recipients past the 36-month entitlement end, for lifetime coverage. A separate Part B-ID premium applies. Coverage is immunosuppressive-only.

How do I apply for Part B-ID?

Apply through the Social Security Administration before your 36-month ESRD entitlement ends. SSA enrolls eligible recipients in Part B-ID, which begins automatically at the end of the 36-month period.

Do I need other coverage if I'm on Part B-ID?

Yes. Part B-ID covers only immunosuppressive drugs and related monitoring. Other Part A and Part B services do not continue. Recipients should have other coverage (Marketplace, Medicaid, COBRA, employer GHP) for non-immunosuppressive medical needs.

What is ESRD Network 6?

ESRD Network 6 (Southeastern Kidney Council) is the federally contracted ESRD Network serving Georgia, North Carolina, and South Carolina under Section 1881(d) of the Social Security Act. Phone 919-855-0882. The Network handles ESRD-specific beneficiary services, quality monitoring, transplant coordination, and data collection.

How do I file a complaint about my dialysis facility?

File with ESRD Network 6 at 919-855-0882 for facility-specific concerns. You can also file with your plan (under 42 CFR 422.564 for MA grievances), with KEPRO (Georgia QIO at 1-844-455-8708) for quality of care reviews, or with CMS through 1-800-MEDICARE.

Where are kidney transplant programs in Georgia?

Major Georgia kidney transplant programs include Emory University Hospital (Atlanta), Piedmont Atlanta Hospital, Wellstar Atlanta Medical Center, Augusta University Medical Center, and Children's Healthcare of Atlanta (pediatric).

What is the difference between in-center hemodialysis and home dialysis?

In-center hemodialysis occurs at a dialysis facility, typically three sessions per week. Home dialysis includes home hemodialysis (daily or alternate-day at home after training) and peritoneal dialysis (CAPD or CCPD, performed at home with peritoneal cavity exchanges). Home dialysis qualifies for Month 1 Medicare entitlement if self-care training begins within 3 months of dialysis start.

How does Medicaid coordinate with Medicare for ESRD?

For QMB-eligible dual-eligibles, Medicaid pays Medicare cost-sharing (premiums, deductibles, coinsurance) under 42 USC 1396a(a)(10)(E)(i). Improper billing protections at 42 CFR 422.504(g)(1) prohibit providers and MA plans from billing QMB beneficiaries for Medicare cost-sharing. For full Medicaid eligibles, Medicaid covers services Medicare does not cover.

What is a D-SNP and why might it help ESRD beneficiaries?

A Dual-Eligible Special Needs Plan (D-SNP) is a Medicare Advantage plan under 42 CFR 422.4 designed for beneficiaries who have both Medicare and Medicaid. D-SNPs coordinate Medicare and Medicaid benefits, often include ESRD-specific case management, and integrate primary care, specialty care (nephrology), and dialysis facility coordination.

Can ESRD beneficiaries get Medigap policies?

Yes, but Medigap availability for ESRD beneficiaries varies by state. Georgia follows federal minimum standards for Medigap (no expanded protections beyond federal). ESRD beneficiaries under 65 may face limited Medigap availability or higher premiums. Beneficiaries 65+ generally have full Medigap access during their open enrollment period.

What is the Part B deductible and how does it apply to dialysis?

The Part B deductible for 2026 is $250 (subject to annual updates). After meeting the deductible, beneficiaries pay 20% coinsurance on Part B services including dialysis. Medigap or Medicaid (for QMB-eligibles) covers the coinsurance for those with secondary coverage.

Report to HHS Office of Inspector General at 1-800-447-8477 (1-800-HHS-TIPS). Examples include billing for services not provided, ESA over-prescribing, kickbacks, and false claims. Dialysis facilities have been a significant focus of OIG fraud enforcement.

Does Brevy have other Georgia Medicare guides?

Yes. For Medicare vs Medicaid coordination, see /medicaid/georgia/medicare-vs-medicaid. For Medicare Advantage, see /medicaid/georgia/medicare-advantage. For Part D, see /medicaid/georgia/medicare-part-d. For QMB protections, see /medicaid/georgia/qualified-medicare-beneficiary. For Medicare Savings Programs, see /medicaid/georgia/medicare-savings-programs. For grievances, see /medicaid/georgia/medicare-grievances. For appeals, see /medicaid/georgia/medicare-appeals-process. For the Medicare Beneficiary Ombudsman, see /medicaid/georgia/medicare-ombudsman. :::

::: cta

Georgia ESRD Medicare Resources and Contacts

If you need help navigating ESRD Medicare in Georgia, contact one or more of the following resources. The Brevy team and brevy.com provide additional written guides at the links above. For individual case assistance, the agencies and organizations below offer free or low-cost help.

Medicare and ESRD-Specific Resources

  • Medicare 1-800-MEDICARE (1-800-633-4227), general Medicare information and plan enrollment
  • ESRD Network 6 (Southeastern Kidney Council) 919-855-0882, ESRD-specific grievances and beneficiary services for Georgia, NC, and SC
  • Social Security Administration 1-800-772-1213, Medicare ESRD application, Part B-ID enrollment, disability and retirement benefits
  • KEPRO (Georgia QIO) 1-844-455-8708, quality of care reviews and hospital discharge appeals

Major Dialysis Providers in Georgia

  • DaVita Kidney Care Guest Services 1-833-336-7997, national chain with numerous Georgia locations
  • Fresenius Kidney Care 1-800-662-1237, national chain with numerous Georgia locations

Kidney Disease Patient Assistance

  • American Kidney Fund 1-800-638-8299, patient financial assistance and education
  • National Kidney Foundation 1-800-622-9010, education, advocacy, and patient services

Georgia State Agencies and Counseling

  • GeorgiaCares (Georgia SHIP) 1-866-552-4464, free Medicare counseling and advocacy
  • Georgia Department of Community Health Medicaid Member Services 1-866-211-0950, dual-eligible Medicaid coordination
  • Georgia Renal Disease Program, state pharmaceutical assistance for kidney disease patients

Federal Oversight and Civil Rights

  • HHS Office of Civil Rights 1-800-368-1019, discrimination complaints under Section 1557 ACA
  • HHS Office of Inspector General 1-800-447-8477 (1-800-HHS-TIPS), Medicare fraud reporting

National Medicare Legal Resources

  • Medicare Rights Center 1-800-333-4114, national Medicare counseling and legal assistance
  • Center for Medicare Advocacy 1-860-456-7790, national Medicare legal advocacy

Georgia Legal Assistance

  • Atlanta Legal Aid Senior Citizens Law Project 404-377-0701, free legal representation for income-qualified Atlanta-area residents
  • Georgia Legal Services Program 1-800-498-9469, free legal representation for income-qualified Georgia residents outside metro Atlanta

Information and Referral

  • 211 Georgia, dial 211 from any phone in Georgia for community resources
  • Eldercare Locator 1-800-677-1116, local Area Agency on Aging connection

This guide is informational and does not constitute legal or medical advice. Medicare ESRD rules, payment systems, and coverage provisions change through CMS rulemaking and federal legislation. Brevy and brevy.com publish updated guides at the canonical Medicaid Georgia hub at /medicaid/georgia. For complex individual cases, consult a Medicare-experienced attorney or contact GeorgiaCares for free SHIP counseling. :::

BC

Brevy Care Team

Expert eldercare guidance from Brevy's team of healthcare professionals and researchers.